1-15 of 63
Applying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome
CME/CEApplying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome
Breaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
CME/CEBreaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
CME/CENo Patient with CKD Left Behind! Emerging CKD Therapies in T1D
Advances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1
CME/CE Broadcast ReplayAdvances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1
The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
CME/CEThe Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
CME/CECase-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
- advertisement
Global Perspectives on New Data in Type 2 Diabetes — Congress-to-Clinic Insights From ADA and EASD 2025
CME/CEGlobal Perspectives on New Data in Type 2 Diabetes — Congress-to-Clinic Insights From ADA and EASD 2025
Risk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
CME/CERisk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
CME/CEChairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
CME/CEContinuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
Stemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
CME/CEStemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
- advertisement
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
MinuteCE®Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
APOC3 Inhibition: A Novel Approach to Lowering TGs
MinuteCE®APOC3 Inhibition: A Novel Approach to Lowering TGs



















































































